Last Updated: November 8, 2026

CLINICAL TRIALS PROFILE FOR DEXAMETHASONE ACETATE

« Back to Dashboard

All Clinical Trials for DEXAMETHASONE ACETATE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003213 ↗	Drugs to Reduce the Side Effects of Chemotherapy	Completed	Swiss Group for Clinical Cancer Research	Phase 3	1996-05-01	RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron is more effective than receiving dexamethasone with metoclopramide for reducing the side effects of chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with either granisetron or metoclopramide in patients treated with chemotherapy.
NCT00091260 ↗	CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis	Completed	Celgene Corporation	Phase 2	2004-01-01	RATIONALE: Drugs such as CC-5013 and dexamethasone may be effective in treating primary systemic amyloidosis. PURPOSE: This phase II trial is studying CC-5013 to see how well it works with or without dexamethasone in treating patients with primary systemic amyloidosis.
NCT00091260 ↗	CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis	Completed	Vaishali Sanchorawala	Phase 2	2004-01-01	RATIONALE: Drugs such as CC-5013 and dexamethasone may be effective in treating primary systemic amyloidosis. PURPOSE: This phase II trial is studying CC-5013 to see how well it works with or without dexamethasone in treating patients with primary systemic amyloidosis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DEXAMETHASONE ACETATE

Condition Name

Chart
Table

Condition Name for DEXAMETHASONE ACETATE
Intervention	Trials
Multiple Myeloma	7
Lymphoma	4
Cataract	4
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DEXAMETHASONE ACETATE
Intervention	Trials
Multiple Myeloma	12
Neoplasms, Plasma Cell	10
Leukemia	7
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DEXAMETHASONE ACETATE

Trials by Country

Map
Table

Trials by Country for DEXAMETHASONE ACETATE
Location	Trials
United States	170
China	17
France	16
Canada	9
Brazil	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DEXAMETHASONE ACETATE
Location	Trials
New York	14
California	13
Massachusetts	12
Texas	10
Ohio	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DEXAMETHASONE ACETATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DEXAMETHASONE ACETATE
Clinical Trial Phase	Trials
PHASE4	1
PHASE3	1
PHASE2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DEXAMETHASONE ACETATE
Clinical Trial Phase	Trials
Completed	30
Recruiting	19
Terminated	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DEXAMETHASONE ACETATE

Sponsor Name

Chart
Table

Sponsor Name for DEXAMETHASONE ACETATE
Sponsor	Trials
National Cancer Institute (NCI)	7
Ocular Therapeutix, Inc.	6
M.D. Anderson Cancer Center	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DEXAMETHASONE ACETATE
Sponsor	Trials
Other	89
Industry	40
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.